SARS-CoV-2 RT-PCR - India CDSCO Medical Device Registration
SARS-CoV-2 RT-PCR is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2021/000085_58d898d79de35d806698714521ebb4c1_f945ad824bd11953ff7f9630ed031c55. This device is marketed under the brand name CLIA. The license holder is DIAGNOSTIC CARE AND TRADING PVT LTD, and it is classified as Device Class Class C. The approving authority is CDSCO.
This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.
Brand Name
CLIA
License Holder
DIAGNOSTIC CARE AND TRADING PVT LTDDevice Class
Approving Authority
CDSCO
Product Information
The SARS-CoV-2 RT-PCR Assay is used for qualitative detection of SARS-CoV-2 from oropharyngeal swabs, nasopharyngeal swabs and BALF (CLIA) of suspected cases of COVID-19.
Testosterone Assay (Testosterone Assay )
Brand: CLIA
Rapid House
MYO Assay (MYO Assay )
Brand: CLIA
Rapid House
Blood Culture Positive Sample Pretreatment Kit
Brand: CLIA
Rapid House
PRL Assay (PRL Assay )
Brand: CLIA
Rapid House
Substrate
Brand: CLIA
Rapid House
FT3 Assay (FT3 Assay )
Brand: CLIA
Rapid House
Mold Sample Pretreatment Kit
Brand: CLIA
Rapid House
Z5 LD Lyse
Brand: CLIA
Rapid House
CK-MB Assay (CK-MB Assay )
Brand: CLIA
Rapid House
T3 Assay (T3 Assay )
Brand: CLIA
Rapid House
25-OH Vitamin D (Maglumi 25-OH Vitamin D )
Brand: CLIA
PRL (Maglumi PRL )
Brand: CLIA
Reaction Module
Brand: CLIA
PRG (Maglumi PRG )
Brand: CLIA
Starter 1+2
Brand: CLIA
TSH (Maglumi TSH )
Brand: CLIA
T4 (Maglumi T4 )
Brand: CLIA
FSH (Maglumi FSH )
Brand: CLIA
SHBG (Maglumi SHBG )
Brand: CLIA
FT4 (Maglumi FT4 )
Brand: CLIA